Literature DB >> 6530535

Autoantibodies and vascular events in essential hypertension: a five-year longitudinal study.

B O Kristensen, P L Andersen, A Wiik.   

Abstract

The relationship between serum autoantibodies and vascular events was investigated in 140 patients with essential hypertension during a five-year period. The influence of time upon incidence of autoantibodies was assessed in 55 normotensive controls of roughly the same distribution of age and sex. Thirty-four patients experienced a vascular event, which was fatal in 10 cases (7.1%). Eight of these 10 patients had autoantibodies in serum before the events, and the presence of autoantibodies at entry to the study tripled the five-year relative risk for vascular events. Antinuclear antibodies (ANA) and smooth muscle antibodies (SMA) especially contributed to this increased risk. The vascular events were followed by a significantly increased occurrence of ANA. In the control subjects no events occurred and no significant increases in the presence of autoantibodies were found during the five years. ANA and SMA positive sera showed no significant complement fixing properties, and the autoantibodies studied seemed to be secondary to tissue damage. Despite this, they seemed to reflect an ongoing injury of the vascular bed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6530535     DOI: 10.1097/00004872-198402000-00004

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  10 in total

1.  Preventing autoimmunity protects against the development of hypertension and renal injury.

Authors:  Keisa W Mathis; Kedra Wallace; Elizabeth R Flynn; Christine Maric-Bilkan; Babbette LaMarca; Michael J Ryan
Journal:  Hypertension       Date:  2014-07-14       Impact factor: 10.190

2.  Biomechanical coupling in renin-releasing cells.

Authors:  R M Carey; H E McGrath; E S Pentz; R A Gomez; P Q Barrett
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 3.  National Heart, Lung, and Blood Institute Working Group Report on Salt in Human Health and Sickness: Building on the Current Scientific Evidence.

Authors:  Young S Oh; Lawrence J Appel; Zorina S Galis; David A Hafler; Jiang He; Amanda L Hernandez; Bina Joe; S Ananth Karumanchi; Christine Maric-Bilkan; David Mattson; Nehal N Mehta; Gwendolyn Randolph; Michael Ryan; Kathryn Sandberg; Jens Titze; Eser Tolunay; Glenn M Toney; David G Harrison
Journal:  Hypertension       Date:  2016-06-20       Impact factor: 10.190

Review 4.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

5.  Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.

Authors:  Erin B Taylor; Michelle T Barati; David W Powell; Hannah R Turbeville; Michael J Ryan
Journal:  Hypertension       Date:  2018-01-29       Impact factor: 10.190

Review 6.  Autoimmunity: an underlying factor in the pathogenesis of hypertension.

Authors:  Keisa W Mathis; Hanna J Broome; Michael J Ryan
Journal:  Curr Hypertens Rep       Date:  2014-04       Impact factor: 5.369

7.  Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease.

Authors:  Erin B Taylor; Michael J Ryan
Journal:  J Am Heart Assoc       Date:  2017-02-27       Impact factor: 5.501

Review 8.  Mosaic theory revised: inflammation and salt play central roles in arterial hypertension.

Authors:  Felicitas E Hengel; Jean-Pierre Benitah; Ulrich O Wenzel
Journal:  Cell Mol Immunol       Date:  2022-03-30       Impact factor: 22.096

Review 9.  Impact of ovarian function on cardiovascular health in women: focus on hypertension.

Authors:  Christine Maric-Bilkan; Emily L Gilbert; Michael J Ryan
Journal:  Int J Womens Health       Date:  2014-01-24

10.  Development of the prediction model for hypertension in patients with idiopathic inflammatory myopathies.

Authors:  Li Qin; Yiwen Zhang; Xiaoqian Yang; Han Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-11       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.